News

The Minnesota Department of Commerce today announced it has levied a $500,000 penalty against Caremark after alleging that Caremark...

The House Energy and Commerce Committee Subcommittee on Health this week held a legislative hearing entitled, “Lowering Unaffordable...

From the early days of the caucuses through the general election, Iowans make a point to ask tough questions that highlight the...

New Poll Finds 87% of Respondents Support Regulating Pharmacy Benefit Managers Salem, Ore. – With the Beaver State already facing...

Several Congressional Committees recently have held hearings where criticism of harmful PBM business practices has taken center stage....

Today, U.S. Representatives Dusty Johnson (R-S.D.) and Abigail Spanberger (D-VA-07) introduced a bipartisan bill that would prohibit...

For the first time, Mark Cuban’s Cost Plus Drug Company is selling medicines made by a large drug manufacturer directly to consumers at a...

46brooklyn is a group of pharmacy experts who set out to educate others about what they had learned about the frustrating complexity of...

The Senate Finance Committee held a hearing on March 30 to discuss how pharmacy benefit managers (PBMs) affect patients and taxpayers....

The pressure on pharmacy benefit managers (PBMs) is ramping up. Both Congress and the Federal Trade Commission (FTC) are probing alleged...

Congress is honing in on how it wants to overhaul the rules of the road for pharmacy benefit managers, with a Senate Finance Committee...

Reduced competition, shortages, and unaffordable options in healthcare are symptoms of middlemen running amok. These middlemen are the...

Unfortunately for Americans, consolidation in the healthcare industry has neither reduced costs nor improved clinical outcomes. 340B...

Bipartisan Respondents Strongly Favor Policies that Require PBMs to Provide Value and Lower Drug Costs Washington, DC – With pharmacy...

While calls to “start over again” and “blow up the whole model” seasoned today’s meeting of the Senate Finance Committee investigating...

Mark Blum, Managing Director of the PBM Accountability Project, issued a statement about the Senate Commerce Committee progress on the...

Eli Lilly & Co. is cutting the list prices for Humalog and Humulin, its two biggest-selling insulin products by 70%. The price cuts will...

House Republicans have launched an investigation into the companies that manage drug benefits, dialing up the scrutiny of the middlemen...

The Senate Commerce Committee held a hearing on Feb. 16 to discuss how pharmacy benefit managers (PBMs) impact patients and community...

Pharmacy benefit managers (PBMs) -- middlemen between pharmacies, health insurers, and drug companies -- are responsible for driving up...

The drumbeat of calls to enact reforms to pharmaceutical middlemen is growing louder after years of largely unsuccessful attempts by...

Pharmacy benefit managers (PBMs) came under some harsh attacks and critiques today at a Senate hearing about legislation that would add...